AI
LLY icon

Axecap Investments’s Eli Lilly LLY Stock Holding History

Axecap Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Buy
3,851
+3,545
+1,158% +$3.62M 2.55% 20
2026
Q1 		$281K Hold
306
– – 0.19% 56
2025
Q4 		$329K Buy
306
+3
+1% +$2.87K 0.2% 63
2025
Q3 		$231K Hold
303
– – 0.14% 77
2025
Q2 		$236K Sell
303
-6
-2% -$4.66K 0.15% 69
2025
Q1 		$255K Sell
309
-54
-15% -$44.9K 0.22% 63
2024
Q4 		$280K Sell
363
-1,037
-74% -$859K 0.21% 63
2024
Q3 		$1.24M Buy
+1,400
New +$1.26M 0.94% 35

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Axecap Investments's LLY Position: Q2 2026 in Review

Axecap Investments increased its Eli Lilly (LLY) stake by 1,158% in Q2 2026, buying an estimated $3.62M and bringing the position to 3,851 shares worth $4.62M. The position accounts for 2.55% of the portfolio, ranked #20.

Axecap Investments first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Axecap Investments held 3,851 shares of Eli Lilly worth $4.62M as of Q2 2026.
  • Axecap Investments bought 3,545 Eli Lilly shares in Q2 2026, an estimated $3.62M.
  • Eli Lilly made up 2.55% of Axecap Investments's portfolio in Q2 2026, its #20 holding.
  • Axecap Investments first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.